Shunts have gained traction as cerebrospinal fluid (CSF) diversion devices in the management of hydrocephalus. The condition is characterized by physiological imbalance due to impairment in production, flow, and absorption of CSF. The global market has evolved steadily over the last few decades, helped by their growing demand as the therapy of choice for the treatment of hydrocephalus. A variety of diseases and injuries may result in the disease condition and their management usually poses considerable challenge to neurophysicians, neurologists, and medical device developers.
Get Sample Copy of this Report @
Growing prevalence of neurological disorders due to imbalance of cerebrospinal fluid in various patient populations is a key factors propelling the demand for hydrocephalus shunts. Growing incidence of this condition in adults, especially in older populations, is also bolstering the demand for hydrocephalus shunts.
Advancements in Shunt Components improve Outcomes in Managing Hydrocephalus
Various shunt components, particularly valves, have been garnering increasing attention by medical device manufacturers over the past few decades. Advances in the materials and the biotechnologies used are expected to improve the functionality of shunt components considerably. This has brought down the risk of shunt malfunctions and is poised to advance neurosurgical patient care. The advent of high impact devices in this regard, notably ventriculoperitoneal shunt, has expanded the prospects substantially. Moreover, the advent of customizable weight valves has opened an entirely new avenue for surgeons.
However, the dynamic that shapes the uptake of hydrocephalus shunts also faces certain setbacks, which needs to be taken care as the market will make rapid strides in coming years. The paucity of clinical expertise in various parts of the world has dampened the demand a bit. Moreover, risk of seepage of CSF from the use of shunts and poor selection of patients may cripple the growth.
Read Comprehensive Overview of Report @
Nevertheless, untreated hydrocephalus in pediatric patients cause varied and serious repercussions in the later years of life, hence medical device manufacturers see great potential in this segment. Advances in neurosurgical patient care are expected to window of opportunities for market players to capitalize on in future.